Fat-induced liver insulin resistance

被引：22

作者：

Pankaj Shah

Ananda Basu

Robert Rizza

机构：

[1] Mayo Clinic and Foundation, Rochester, MN 55905

来源：

Current Diabetes Reports | 2003年 / 3卷 / 3期

关键词：

Free Fatty Acid; Lipid Emulsion; Endogenous Glucose Production; Hepatic Insulin Resistance; Plasma FFAs;

D O I：

10.1007/s11892-003-0066-1

中图分类号：

学科分类号：

摘要：

In vitro studies have established that free fatty acids (FFAs) are important regulators of hepatic glucose metabolism. FFAs can increase hepatic glucose release by increasing the amount and activity of glucose-6-phosphatase and multiple gluconeogenic enzymes. Elevated FFAs can also potentially decrease hepatic glucose uptake by decreasing hepatic glucokinase activity. In vivo studies in both animals and humans have shown a close correlation between changes in plasma FFAs and endogenous glucose production (EGP). Intervention studies have established that changes in plasma FFAs are accompanied by changes in the relative contribution of gluconeogenesis and glycogenolysis to EGP. The effects of a change in FFAs on EGP itself are more evident when compensatory changes in insulin secretion are prevented or when insulin secretion is impaired (eg, diabetes mellitus). The effects of elevated FFAs on splanchnic glucose uptake are less clear, in that they appear to have no effect in nondiabetic humans and may impair uptake in people with type 2 diabetes. Copyright © 2003 by Current Science Inc.

引用

页码：214 / 218

页数：4

共 54 条

[1]

Gorden E.S., Nonesterified fatty acids in blood of obese and lean subjects, Am. J. Clin. Nutr., 8, pp. 740-747, (1960)

[2]

Reaven G.M., Syndrome X: 6 years later, J. Int. Med., 736, pp. 13-22, (1994)

[3]

Reaven G.M., Hollenbeck C., Jeng C.Y., Et al., Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 hours in patients with NIDDM, Diabetes, 37, pp. 1020-1024, (1988)

[4]

Jouven X., Charles M.A., Desnos M., Ducimetiere P., Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population, Circulation, 104, pp. 756-761, (2001)

[5]

Randle P.J., Hales C.N., Garland P.B., Newsholm E.A., The glucose fatty-acid cycle: Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus, Lancet, 1, pp. 7285-7289, (1963)

[6]

Boden G., Chen X., Ruiz J., Et al., Mechanisms of fatty acid-induced inhibition of glucose uptake, J. Clin. Invest., 93, pp. 2438-2446, (1994)

[7]

Kelley D.E., Mokan M., Simoneau J.-A., Mandarino L.J., Interaction between glucose and free fatty acid metabolism in human skeletal muscle, J. Clin. Invest., 92, pp. 91-98, (1993)

[8]

Tippett P.S., Neet K.E., Specific inhibition of glucokinase by long chain acyl coenzymes A below the critical micelle concentration, J. Biol. Chem., 257, pp. 12839-12845, (1982)

[9]

Hue L., Maisin L., Rider M.H., Palmitate inhibits liver glycolysis: Involvement of fructose 2,6-biophosphate in the glucose/fatty acid cycle, Biochem. J., 251, pp. 541-545, (1988)

[10]

Chatelain F., Pegorier J.-P., Minassian C., Et al., Development and regulation of glucose-6-phosphatase gene expression in rat liver, intestine, and kidney: In vivo and in vitro studies in cultured fetal hepatocytes, Diabetes, 47, pp. 882-889, (1998)

← 1 2 3 4 5 6 →